- Home
- BOLD vs SDST Comparison
BOLD vs SDST Comparison
Compare BOLD & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- SDST
- Stock Information
- Founded
- BOLD 2018
- SDST 2022
- Country
- BOLD United States
- SDST United States
- Employees
- BOLD N/A
- SDST N/A
- Industry
- BOLD
- SDST Blank Checks
- Sector
- BOLD
- SDST Finance
- Exchange
- BOLD Nasdaq
- SDST Nasdaq
- Market Cap
- BOLD 30.3M
- SDST 33.1M
- IPO Year
- BOLD 2024
- SDST N/A
- Fundamental
- Price
- BOLD $1.44
- SDST $0.50
- Analyst Decision
- BOLD Hold
- SDST Strong Buy
- Analyst Count
- BOLD 1
- SDST 2
- Target Price
- BOLD N/A
- SDST $1.73
- AVG Volume (30 Days)
- BOLD 61.2K
- SDST 523.1K
- Earning Date
- BOLD 05-09-2025
- SDST 05-14-2025
- Dividend Yield
- BOLD N/A
- SDST N/A
- EPS Growth
- BOLD N/A
- SDST N/A
- EPS
- BOLD N/A
- SDST N/A
- Revenue
- BOLD N/A
- SDST N/A
- Revenue This Year
- BOLD N/A
- SDST $4,114.37
- Revenue Next Year
- BOLD N/A
- SDST N/A
- P/E Ratio
- BOLD N/A
- SDST N/A
- Revenue Growth
- BOLD N/A
- SDST N/A
- 52 Week Low
- BOLD $1.06
- SDST $0.41
- 52 Week High
- BOLD $12.26
- SDST $28.38
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- SDST N/A
- Support Level
- BOLD N/A
- SDST N/A
- Resistance Level
- BOLD N/A
- SDST N/A
- Average True Range (ATR)
- BOLD 0.00
- SDST 0.00
- MACD
- BOLD 0.00
- SDST 0.00
- Stochastic Oscillator
- BOLD 0.00
- SDST 0.00
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).